E-DRUG: Drug Therapy Committees and Training of Trainers Course
-----------------------------------------------------------
ANNOUNCEMENT
International Training Course on Drug & Therapeutics Committees and
Training of Trainers, November 28 to December 10, 2005, Penang, Malaysia
The National Poison Center in Malaysia will host an International Course on Drug and Therapeutics Committees and Training of Trainers from November 28 to December 10, 2005, in Penang, Malaysia. The course is organized by the University of Science Malaysia (USM) and the
Rational Pharmaceutical Management Plus (RPM Plus) Program of Management Sciences for Health (MSH) in collaboration with the World Health Organization (WHO) Department of Medicines Policies and Standards. The Course is supported by the U.S. Agency for International Development.
Who Should Attend?
------------------
The course is designed for physicians; pharmacists; and health officials in hospitals, ministries of health, universities, or private organizations. Those interested in improving formulary management and promoting rational use of medicines through Drug and Therapeutics
Committees (DTCs) and who are in a position to provide training and technical assistance to other DTCs are invited to apply. Candidates with some experience with DTCs and who wish to expand their knowledge of pharmaceutical management and train others in their country/region are preferred.
Course Focus
------------
The training course will focus on the role of the DTC and the practical approaches available in promoting rational use of medicines. Key features will include -
* Formulary management
* Standard treatment guidelines
* Essential medicines list
* Indicators of medicine use
* Interventions to change
*inappropriate medicine use
* Practical aspects of running a DTC
The last two days of the course will focus on training of trainers (TOT) aspect and is designed to help the participants to better prepare themselves to provide DTC-related training to others in their respective countries and regions. Key features of the TOT component will include -
* Adult learning
* Role of the teacher
* Communication skills
* Teaching and learning methods
* DTC-related presentation and facilitation skills
Design and Methods
------------------
The highly participatory course will be conducted in English and will
consist of-
* Presentations
* Discussions
* Small group activities
* Field visits
The DTC training will be based on materials developed by MSH in collaboration with WHO, and will allow for the exchange of experiences and ideas among participants, adding depth to the learning process. This will expose participants to a wide range of international experiences
and materials. The TOT training will be based on the materials recently developed by MSH. The course materials will emphasize-
* Identifying and understanding medicine use problems
* Formulary management and standard treatment guidelines
* Assessing pharmaceutical efficacy, safety, and quality
* Cost evaluation of formulary pharmaceuticals
* Drug utilization reviews
* Strategies to improve medicine use
* Structure and function of a DTC
* Infection control
* Monitoring and evaluating a DTC
* Local hospital field study
* Adult learning and teaching learning methods
* Communication, presentation, and facilitation skills
Faculty
-------
A team of experts from USM, RPM Plus/MSH, and WHO will serve as
trainers. They include-
Dr. Budiono Santoso is currently the Regional Advisor in Pharmaceuticals of the Western Pacific Regional Office of the World Health Organization. He is a medical doctor and clinical pharmacologist by training, earning his medical degree at Gadjah Mada University (Yogyakarta, Indonesia) in 1975 and his doctoral degree at University Newcastle Upon Tyne (UK) in 1983. Formerly, he was the Director of the WHO Collaborating Centre on Research and Training on Rational Drug Use at the Centre of Drug Policy Studies, Gadjah Mada University, and Head of Clinical Pharmacology at the Medical School of that university until 1999. He was one of the
founding members of the International Network for Rational Use of Drugs (INRUD), and formerly served as the Subcommittee Chairman for Clinical Pharmacology in Developing Countries of the Division of Clinical Pharmacology of the International Union of Pharmacology (IUPHAR)
(1996-2004). He has served as an Advisory Expert Panel Member on International Health of the U.S. Pharmacopeia. His professional expertise and interests include clinical pharmacology, drug utilization, rational use of medicines, and access to medicines. He was previously
involved in a number of international training courses related to rational use of medicines and pharmaceuticals undertaken by WHO, INRUD, MSH, and the World Bank.
Dr. Kathleen Holloway is a medical officer with the World Health Organization Department of Medicines Policies and Standards (WHO/PSM) in Geneva. Her present responsibility is the promotion of the rational use of medicines at both global and country levels, and she is actively
involved in training programs, research, and capacity building in this area. Her professional experience includes 10 years as a clinician in the UK National Health Service, 10 years working in Asia in both clinical medicine and public health, and 5 years working in international health. She spent 1991-1998 in Nepal managing an essential medicines program, and she conducted research into the effects of user fees on rational use of medicines. Dr. Holloway is particularly
interested in financial mechanisms to promote more rational use of medicines and in containing antimicrobial resistance.
Dr. Mohan P. Joshi is Program Manager for Antimicrobial Resistance at the RPM Plus Program of MSH's Center for Pharmaceutical Management. He is a medical doctor with postgraduate degrees in clinical pharmacology (MSc) and pharmacology (MD). Dr. Joshi has 22 years of professional
experience and worked as Assistant Dean, Professor, and Head of Clinical Pharmacology, as well as Director of the Drug Information Center, at the Tribhuvan University Institute of Medicine in Nepal before joining MSH. Dr. Joshi has served as a member of the International Health Expert
Advisory Panel of the U.S. Pharmacopeia. He has coordinated or facilitated many training courses on rational use of medicines, including regional courses on Promoting Rational Drug Use (PRDU) and Drug and Therapeutics Committees that included modules on Training of Trainers. His areas of interest and experience include clinical pharmacology, medical education, rational use of medicines, drug utilization, drug information, drug formularies, DTCs, and antimicrobial
resistance.
Dr. Mohd. Baidi Bahari is an Associate Professor and serves as Chairman of the Clinical Pharmacy Program in USM's School of Pharmaceutical Sciences. He obtained his postgraduate degree from the University of Minnesota. Dr. Baidi has more than 20 years of clinical experience, having served as Head of the Aseptic Dispensing Unit, a member of the Pharmacy and Therapeutics Committee, and a member of the Infectious Disease Committee at USM Teaching Hospital. He is also a member of the National Accrediting Board for the School of Pharmacy and a Council
Member of the Malaysian Pharmaceutical Society. Dr. Baidi is the current Chairman of the Continuing Pharmacy Development Program of the Malaysian Pharmacy Board.
Ms. Olya Duzey is Program Manager for Asia and the Near East (ANE) with the MSH Center for Pharmaceutical Management, RPM Plus Program, where she has designed, implemented, managed, and evaluated country and regional programs in Asia for the RPM Plus and Strategies for Enhancing Access to Medicines (SEAM) programs, as well as in countries of the
Newly Independent States. Ms. Duzey has over 25 years of professional experience, including community health education; hospital, community, and professional association pharmacy practice; and international pharmaceutical management. With RPM Plus, she provides technical
assistance in community drug use practices in malaria and child survival, distribution, retail pharmacy management, planning and conducting countrywide and focused pharmaceutical assessments, and facilitating strategy development and policy implementation. Ms. Duzey
also conducts training in various pharmaceutical management courses; guest lectures at Georgetown University; and has served on various professional, academic, and community advisory boards and committees, including the U.S. Pharmacopeial Convention's Advisory Panel on Pharmacy Practice.
Professor Rahmat Awang is the Director of the National Poison Centre of Malaysia/WHO Collaborating Centre for Drug Information based at USM. He received his Doctor of Pharmacy degree from the University of Minnesota in 1985 and was a recipient of the Dean's Award for excellent performance in Clinical Pharmacy in his graduating year. Professor Rahmat pioneered and served as Head of the Drug Information Service at USM's Teaching Hospital. Professor Rahmat's research interests include the development of a computerized pharmacy-based system, drug utilization studies, and clinical toxicology.
Dr. Syed Azhar Syed Sulaiman is an Associate Professor and Deputy Dean (Student Affairs) in the School of Pharmaceutical Sciences, USM, Penang. A clinical pharmacist by training, Dr. Syed Azhar obtained his Doctor of Pharmacy degree from the University of Michigan, specializing in
Infectious Diseases, Geriatrics, and Pharmacoeconomics. He is an associate member of the National Poison Centre of Malaysia and is the current President of the Asian Conference in Clinical Pharmacy. Dr. Syed Azhar actively promotes rational use of medicines in the South East Asia region.
Mr. Terry Green is a Clinical Pharmacist with the U.S. Public Health Service. He has worked with Management Sciences for Health in their antimicrobial resistance activities. This work included the development and implementation of training materials for the International DTC training Philippines, Indonesia, Kenya, Nepal, and Jordan. He has 25 years of experience in public health pharmaceutical programs.
Dr. Yahaya Hassan, Pharm.D., is an Associate Professor in Clinical Pharmacy at USM's School of Pharmaceutical Sciences. He received his Doctor of Pharmacy degree from the University of Minnesota. Dr. Yahaya maintains an active clinical pharmacy practice in the Department of
Medicine in the Penang Hospital. He is an active member of the American College of Clinical Pharmacy (ACCP) and European Society for Clinical Pharmacy (ESCP). Dr. Yahaya's research interests include drug utilization studies and pharmaceutical outcomes. He is a consultant to
various pharmaceutical manufacturers for generic bioequivalence studies and therapeutic equivalence trials.
Fees and Application
--------------------
The course fee is USD 1,700. This fee covers tuition, training course
materials, shared accommodations, breakfast, and lunch. Those who
require single room accommodations are required to pay extra charges
(information available on request).
Participants will be provided USD 20 per day to cover dinner expenses.
Participants should plan to bring sufficient money for incidental
expenses like laundry, postage, phone calls, and so on. Travel and
health insurance are the responsibility of the sponsoring organization.
The course fee for local participants not requiring accommodations is
USD 750. This fee covers tuition, training course materials, and lunch.
It does not cover transportation to and from the course, breakfast,
dinner, or hotel accommodations.
Participants should arrive in Penang, Malaysia, on November 27, 2005.
The Local Organizing Committee will be responsible for hotel
accommodations until 10:00 a.m. on December 11, 2005. Those who wish to
stay longer will have to pay for accommodations after that time.
Places for 35 participants (national and international) will be
available. Selection will be based on prior experience, interest in
promoting rational use of medicines through a DTC, and ability to
implement such programs in their own environment.
Bank Details
------------
Bank drafts (checks) should be made payable to USAINS HOLDING SDN. BHD. in U.S. dollars.
Wire transfers can be sent to:
Account name: USAINS Holding Sdn. Bhd.
Account no: 0709 000 6708-05-7
Bank Name: BUMIPUTRA COMMERCE BANK
Bank Address: Universiti Sains Malaysia, Pulau Pinang (018), Malaysia
Swift Code: BCBMMYKL
Deadline for Application
------------------------
Applications and fees are due no later than October 24, 2005. Because the course is limited to 35 participants, applicants are encouraged to apply early.
For a copy of the application form and this course flyer, please visit
http://erc.msh.org/dtc or http://www.msh.org/projects/rpmplus/3.4.htm
For further information, please send an e-mail to Ms. Lucy Chuah at lucyc@notes.usm.my
with a copy to Dr. Mohan P. Joshi at mjoshi@msh.org
----------------------------
Mohan P. Joshi, MBBS, MSc, MD
Program Manager for Antimicrobial Resistance
Rational Pharmaceutical Management Plus Program
Center for Pharmaceutical Management
Management Sciences for Health
4301 North Fairfax Drive, Suite 400
Arlington, VA 22203-1627, USA
Tel Main: 703-524-6575
Tel Direct: 703-248-1635
Fax: 703-524-7898
Email: mjoshi@msh.org
URL: http://www.msh.org